Rotate device

Please turn your device

Bormioli Pharma issues a binding offer to acquire GCL Pharma Srl

Bormioli Pharma 18 March 2020

Bormioli Pharma, a Company leader in the production of pharmaceutical glass and plastic primary packaging, continues investing to become a stronger player in the sector.

This further acquisition, that follows the one of Remy & Geiser completed last Autumn, would allow the Company to enlarge its product range consolidating its ability to support the most demanding Pharma players.

Parma, 18/03/2020 – Bormioli Pharma announces today the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures Group, specialised in the production of plastic, rubber and aluminium closures for pharmaceutical applications.

In 2019 GCL Pharma recorded a turnover of approximately 8 M€. Over the years the company has demonstrated strong innovation capabilities by continuously improving its product range to meet the most stringent pharma standards. The company main premises and production plant are located in Vasto (Chieti).

The aggregate purchase price offered for the acquisition is 8,9 M€.

“With the acquisition of GCL Pharma, we will continue our growth path. – says Andrea Lodetti, CEO of Bormioli Pharma – We aim to strengthen our industrial footprint by adding new technologies that allow to extend our product range, especially in the oral and parenteral segments, activating further business synergies”.

Marco Giovannini, Group Chairman and CEO of Guala Closure Group commented: “This disposal will allow the Guala Closures Group to fully-focus on its core business, and specifically on high value closures with increased growth prospective, including connected closures”.

Closing of the transaction is expected in the next few weeks.

Guala Closures Group
Guala Closures Group has more than 4,700 employees and operates in 5 continents through 30 production plants and markets its products in over 100 countries. Today the Group sells nearly 20 billion closures yearly, with a 2019 turnover of 607 million Euros. Thanks to a policy of continuous business development and technological innovation, the Group is recognized as a global point of reference in the production of alcohol safety closures and is a leading manufacturer of aluminium closures for spirits, wines and beverages.
From August 2018, Guala Closures S.p.A. has been listed on the STAR segment of the Italian Stock Exchange, entering the FTSE Italia Mid Cap index in September 2019.

Bormioli Pharma 18 March 2020